Founded Year

2018

Stage

Series B | Alive

Total Raised

$74.1M

Last Raised

$44M | 2 mos ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+129 points in the past 30 days

About Cyted Health

Cyted Health focuses on non-endoscopic diagnostics within the healthcare industry. The company provides a diagnostic platform that allows for cell collection related to esophageal health. Cyted Health's technology is utilized in sectors that address preventive healthcare and disease intervention. It was founded in 2018 and is based in Cambridge, United Kingdom.

Headquarters Location

149 Cherry Hinton Road Ground Floor Building 3, Old Swiss

Cambridge, England, CB1 7BX,

United Kingdom

+44 (0)1223 737800

Loading...

Cyted Health's Product Videos

ESPs containing Cyted Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Care Delivery & Navigation Tech

The endoscopy imaging analysis platforms market aims to improve the accuracy and standardization of endoscopic procedures through the use of artificial intelligence. This technology can potentially assist gastroenterologists in identifying precancerous lesions, detecting missed adenomas, and classifying and detecting early gastric cancers. Additionally, AI-driven algorithms and computer vision adv…

Cyted Health named as Outperformer among 8 other companies, including Medtronic, Proscia, and Ambu.

Cyted Health's Products & Differentiators

    The Cytosponge test

    A minimally-invasive diagnostic test for early oesophageal cancer and its earliest pre-cancerous form, Barrett’s Oesophagus, the Cytosponge test (£280 excl VAT) is a tool to triage and prioritise patients for upper GI endoscopy. The technology has been evaluated through a series of clinical trials over the past decade, demonstrating that it is well-tolerated by patients with high specificity (92%) and sensitivity (80%, higher for clinically significant findings). Following recommendations by NICE and the British Society for Gastroenterology in 2020, the test has been rolled out through NHS Scotland and NHS England to over 45 hospitals and over 5000 patients across the UK with reflux symptoms and Barrett’s Oesophagus at risk of oesophageal cancer. Demo video: https://www.youtube.com/watch?v=swPrjzOAGkc

Loading...

Research containing Cyted Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Cyted Health in 2 CB Insights research briefs, most recently on Oct 28, 2025.

Expert Collections containing Cyted Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cyted Health is included in 3 Expert Collections, including Artificial Intelligence (AI).

A

Artificial Intelligence (AI)

16,578 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

D

Digital Health

12,122 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

O

Oncology Tech

571 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.

Cyted Health Patents

Cyted Health has filed 2 patents.

The 3 most popular patent topics include:

  • digestive system
  • gastrointestinal cancer
  • infectious causes of cancer
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/16/2024

Digestive system, Infectious causes of cancer, Rare cancers, Gastrointestinal cancer, Oncology

Application

Application Date

2/16/2024

Grant Date

Title

Related Topics

Digestive system, Infectious causes of cancer, Rare cancers, Gastrointestinal cancer, Oncology

Status

Application

Latest Cyted Health News

Digital Health Coffee Time Briefing ☕

Sep 23, 2025

June 15, 2021 Your morning summary of digital health news, information and events to know about if you want to be “in the know”. 👇 News 🏃‍♀️ A partnership between Bupa and GoJoe is aiming to help business health insurance customers increase activity levels and improve workplace health and wellbeing through an app for customers. The GoJoe App uses a combination of gamified challenges, social motivation, real-time tracking and expert-led content. 👨‍💻 Software firm Iodx has released Lilie 9.5 – the latest version of its flagship electronic patient record platform (EPR) which is purpose-built for sexual health services. The update, which launched on 2 September 2025, includes enhancements to streamline workflows, improve patient engagement and support digital transformation. 🧘‍♂️ Digital therapeutics developer Healthy Mind has acquired specialists in therapeutic virtual therapy firm Rescape Innovation. The move will help strengthen Healthy Mind’s presence in the UK and allow it to expand its library of therapeutic VR experiences. 😊 Patients Know Best (PKB) is now live in Germany, as the platform is reshaping how mental health services are delivered with Integrierte Versorgung integrated care platform. With PKB, professionals can onboard patients and create shared records in alignment with Germany’s Coordinated Structured Care guidelines. 🚦 Gastrointestinal molecular diagnostics firm Cyted Health , has secured $44m (£32m) in Series B financing to accelerate the US expansion of its diagnostic platform. It will also help consolidate its existing commercial success across the UK and expand its portfolio of diagnostic tests. ❓Did you know? Outdated technology could be putting vulnerable individuals at risk, according to research from Canary Care . The provider of intelligent activity monitoring, polled UK care workers and found that nearly one in two said outdated tech is a safety risk for vulnerable people. In one case, outdated IT prevented lab results from syncing with records, which led to critical sepsis tests being delayed for hours. Despite this, opinions on tech enabled care, such as intelligent activity monitoring tools, were overall positive. Two thirds agreed that it helps to catch early deterioration, with 76% believing it will help people to stay independent and 79% saying it could save lives or avoid complication. Care workers also estimate that, when used effectively, remote monitoring could redirect around 31% of their workload to higher value tasks. 📖 What we’re reading In a blog post for The King’s Fund , published on 8 September 2025, Danielle Jefferies, senior analyst, warns that the overall rankings of NHS trusts in league tables may be too simplified to show how NHS hospitals are faring for their different services. Jefferies writes : “For league tables to be useful to the public, they should help people to understand what to expect if they join the elective waiting list, attend A&E, are waiting for a cancer diagnosis, and so on. And they should help people to hold local leaders to account if their local services are not up to scratch.” She argues that there is no reliable relationship between how well a hospital trust ranks on its four-hour A&E wait times and how well it ranks for its 18-week elective waiting times or its 28-day faster cancer diagnosis. No single rank can give a meaningful understanding of how well a hospital performs, as variations across services exist. Instead, Jefferies suggests the government should work with the public to determine what level of detail would be most useful to them. She also proposes an alternative that could be fairer, whereby ranking systems compared trusts to their individual performance improvement goals, rather than comparing to other trusts. 🚨Upcoming events

Cyted Health Frequently Asked Questions (FAQ)

  • When was Cyted Health founded?

    Cyted Health was founded in 2018.

  • Where is Cyted Health's headquarters?

    Cyted Health's headquarters is located at 149 Cherry Hinton Road, Cambridge.

  • What is Cyted Health's latest funding round?

    Cyted Health's latest funding round is Series B.

  • How much did Cyted Health raise?

    Cyted Health raised a total of $74.1M.

  • Who are the investors of Cyted Health?

    Investors of Cyted Health include Morningside Ventures, BGF, EQT, British Business Bank, Advent Life Sciences and 9 more.

  • Who are Cyted Health's competitors?

    Competitors of Cyted Health include SYNLAB and 1 more.

  • What products does Cyted Health offer?

    Cyted Health's products include The Cytosponge test and 1 more.

  • Who are Cyted Health's customers?

    Customers of Cyted Health include NHS Scotland and NHS England.

Loading...

Compare Cyted Health to Competitors

SYNLAB Logo
SYNLAB

SYNLAB specializes in medical diagnostic services and specialty testing within the healthcare sector. The company offers a comprehensive range of laboratory testing and diagnostics to support clinical decision-making for patients, healthcare providers, and other entities. SYNLAB primarily serves the healthcare industry, providing essential diagnostic information for patient care and well-being. It was formerly known as Synlab Holding. It was founded in 1998 and is based in Munich, Germany.

Labcorp Logo
Labcorp

Labcorp operates as a healthcare diagnostics company that provides clinical laboratory services and drug development support. The company offers various diagnostic tests and services, including genetic testing, cancer screening, and wellness programs. Labcorp serves patients, healthcare providers, organizations, and biopharmaceutical companies. Labcorp was formerly known as National Health Laboratories. It was founded in 1969 and is based in Burlington, North Carolina.

Dynacare Logo
Dynacare

Dynacare operates as a company that provides diagnostic laboratory testing and various health-related services to hospitals, healthcare professionals, corporate clients, and the general public. Dynacare's services include specimen collection, testing, and reporting, as well as health information and genetic testing. Dynacare was formerly known as Gamma-Dynacare Medical Laboratories. It was founded in 1997 and is based in Brampton, Canada. In July 2002, Dynacare was acquired by LabCorp.

Medicover Logo
Medicover

Medicover provides healthcare and diagnostic services within the healthcare sector. The company offers services including preventive care, outpatient care, specialist healthcare, fertility treatments, dental services, optician services, and wellbeing solutions. Medicover also provides clinical laboratory services, from routine tests to advanced tests, for the monitoring of treatments. It was founded in 1995 and is based in Stockholm, Sweden.

Unilabs Logo
Unilabs

Unilabs operates as an international provider of diagnostic services in the healthcare sector. The company offers a range of diagnostic services including laboratory testing, imaging diagnostics, and pathology services. These services are utilized by healthcare providers, pharmaceutical companies, and the general public. It was founded in 1987 and is based in Geneva, Switzerland. In December 2021, Unilabs was acquired by AP Moller Holding.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.